Labeling OTC Human Drug Products Updating Labeling in RLDs and ANDAs
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 18, 2002
April 24, 2020
f3147bb2-3c37-41e5-8e86-75e7c535af06
Related Documents
Prussian Blue Drug Products — Submitting a New Drug Application
Guidance DocumentFebruary 4, 2003Center for Drug Evaluation and Research
Nonclinical Safety Evaluation of Pediatric Drug Products
Guidance DocumentFebruary 15, 2006Center for Drug Evaluation and Research
Labeling OTC Human Drug Products Using a Column Format
Guidance DocumentDecember 19, 2000Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.